Tango Therapeutics (TNGX)
(Delayed Data from NSDQ)
$5.15 USD
-0.29 (-5.24%)
Updated Nov 1, 2024 04:00 PM ET
After-Market: $5.15 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth A Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/13/2024
Time: -- |
9/2024 | $-0.34 | 0.00% |
Earnings Summary
For their last quarter, Tango Therapeutics (TNGX) reported earnings of -$0.24 per share, beating the Zacks Consensus Estimate of $-0.34 per share. This reflects a positive earnings surprise of 29.41%. Look out for TNGX's next earnings release expected on November 13, 2024. For the next earning release, we expect the company to report earnings of -$0.34 per share, reflecting a year-over-year decrease of 47.83%.
Earnings History
Price & Consensus
Zacks News for TNGX
Amgen (AMGN) Expected to Beat Earnings Estimates: Should You Buy?
TNGX: What are Zacks experts saying now?
Zacks Private Portfolio Services